Canary Sets Up Injective Trust, ETF Could Be on the Way

• Canary Capital formed a Delaware trust for a potential Injective staking ETF, combining spot exposure with staking rewards.
• Injective network surpassed 2 billion transactions with 0.6s finality and 25,000 TPS without interruptions.

Canary Capital has officially formed a trust in Delaware called the “Canary Staked INJ ETF.” Not just any trust, its main purpose is to pave the way for a new ETF that not only presents the spot price of Injective’s INJ token, but also includes the results of staking.

Yes, a combination of asset exposure and passive income from staking in one product. Quite tempting, especially for investors who are lazy to bother with manual staking.

BREAKING: CANARY STAKED $INJ ETF REGISTERED IN DELAWARE

— Injective (@injective) June 9, 2025

Although this trust has not automatically turned into an official ETF, the establishment of a legal entity in Delaware is often an early signal of seriousness, such as when a company prepares to file Form S-1 documents with the SEC or 19b-4 to the relevant exchange. However, don’t rush to set high expectations. The SEC approval process is usually full of twists and turns, especially when staking starts to interfere in the product structure.

On the one hand, it can be seen as innovation, but from the regulator’s perspective, this is prone to being highlighted because it could enter the scene of investment products that require a stricter legal framework.

Injective Strengthens Its Ecosystem with Strategic Institutional Moves

Interestingly, the excitement behind this ETF plan is not the only breath of fresh air for Injective. CNF previously reported that BitGo, one of the major players in digital asset custody services, has officially joined as a validator on the Injective network.

Not only as a validator, BitGo also immediately integrated INJ token support into their platform. This clearly strengthens Injective’s position in the institutional ecosystem, especially amid the staking trend which is increasingly being eyed as an additional source of yield.

Furthermore, since last March, Injective has also partnered with Google Cloud as a validator. This is not just a formal collaboration. Injective’s developer suite can now be accessed directly via the Google Cloud Web3 Portal, complete with BigQuery to pull real-time data, to the implementation of the AI ​​Agent Hackathon which brings together developers from all over.

If analogized, this is like a giant digital “coworking space” environment, where developers can build dApps, pull data, and experiment with AI at the same time—without having to leave one platform.

Not only that, Injective also emphasized its position on the policy advocacy path. On March 30, 2025, they joined the Blockchain Association as an official member alongside big names like Coinbase and Circle.

Injective’s inclusion in this group opens the door for greater involvement in the regulatory process in Washington, D.C., especially when it comes to the stability of industry policy and the security of the Web3 ecosystem.

Unmatched Speed and Reliability in a Crowded Blockchain Space

One thing that often goes unnoticed is Injective’s network performance. Previously, CNF reported that as of the end of May, Injective’s network had completed more than two billion on-chain transactions without a single delay or error.

Block finality times are just 0.6 seconds, and their throughput is capable of accommodating more than 25,000 transactions per second (TPS). In short, if blockchain networks were toll roads, Injective is a highway that never gets stuck—and always runs.

Meanwhile, as of press time, INJ is changing hands at about $13.70, up 2.31% over the last 24 hours and 5.52% over the last 7 days.